LoginSignup
CV

CapsoVision, Inc.

Stock
Stock
Ticker: CV
CV

Price

Price

CHART BY

Frequently asked questions

What is CapsoVision, Inc.'s market capitalization?

The market capitalization of CapsoVision, Inc. is $370.80M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for CapsoVision, Inc.?

CapsoVision, Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.542. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for CapsoVision, Inc.'s stock?

Currently, 2 analysts cover CapsoVision, Inc.'s stock, with a consensus target price of $10.50. Analyst ratings provide insights into the stock's expected performance.

What is CapsoVision, Inc.'s revenue over the trailing twelve months?

Over the trailing twelve months, CapsoVision, Inc. reported a revenue of $13.55M.

What is the EBITDA for CapsoVision, Inc.?

CapsoVision, Inc.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$24.76M. EBITDA measures the company's overall financial performance.

What is the free cash flow of CapsoVision, Inc.?

CapsoVision, Inc. has a free cash flow of -$22.95M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does CapsoVision, Inc. have, and what sector and industry does it belong to?

CapsoVision, Inc. employs approximately 99 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of CapsoVision, Inc.'s shares?

The free float of CapsoVision, Inc. is 30.47M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$370.80M
EPS (TTM) 
-$0.542
Free Float 
30.47M
Revenue (TTM) 
$13.55M
EBITDA (TTM) 
-$24.76M
Free Cashflow (TTM) 
-$22.95M

Pricing

52W span
$3.475$15.26

Analyst Ratings

The price target is $10.50 and the stock is covered by 2 analysts.

Buy

2

Hold

0

Sell

0

Information

CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.

Employees
99
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
CV
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin